An Evaluation of the Safety and Immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled study
bioRxiv (2022) - Comments
doi: 10.1101/2022.07.14.22277617 

Julio Torales, Osmar Cuenca-Torres, Laurentino Barrios, Luis Armoa- Garcia, Gladys Estigarribia, Gabriela Sanabria, Meei-Yun Lin, Josue Antonio Estrada, Lila Estephan, Hao-Yuan Cheng, Charles Chen, Robert Janssen, Chia-En Lien